Use of long acting injectable aripiprazole before and through pregnancy in bipolar disorder: a case report.

Isabel Ballester-GraciaMiriam Pérez-AlmarchaAna Galvez-LlompartMiguel Hernandez-Viadel

Published in: BMC pharmacology & toxicology (2019)

As far as we know, this is the first case report on aripiprazole LAI use during pregnancy. Although we exercise caution in drawing conclusions from a single case, and each case should be weighed up individually, aripiprazole LAI could be a therapeutic option in similar circumstances.

Keyphrases

bipolar disorder
case report
major depressive disorder
high intensity
preterm birth
physical activity
pregnant women
resistance training
hyaluronic acid
tissue engineering